The Healthcare Innovation Portfolio delivered a mixed week, with Doximity (DOCS) and Inspire Medical Systems (INSP) posting strong gains, while TransMedics (TMDX) and Globus Medical (GMED) declined. All positions remain within their minimum holding periods and continue to align with the healthcare technology theme.
Performance Overview
- Doximity (DOCS): +12.02% – Benefiting from strong digital health adoption and positive sector sentiment.
- Inspire Medical (INSP): +11.46% – Continued momentum in sleep apnea treatment innovation.
- Butterfly Network (BFLY): +4.26% – Steady progress in point-of-care ultrasound adoption.
- TransMedics (TMDX): -5.78% – Pullback on profit-taking after recent run-up; fundamentals intact.
- Globus Medical (GMED): -2.07% – Minor decline amid broader market rotation; no thesis change.
Theme Alignment
All holdings are directly tied to healthcare innovation: digital health (DOCS), medical devices (INSP, BFLY, GMED), and organ transplant technology (TMDX). The portfolio remains well-diversified across sub-sectors within the theme.
Risk & Concentration
No single position exceeds 25% of the portfolio. Thematic concentration is high, but intentional given the portfolio’s mandate. Key risks include regulatory changes, reimbursement shifts, and competitive dynamics.
What to Watch
- Earnings reports for DOCS and INSP in the coming weeks.
- FDA updates on new device approvals for BFLY and GMED.
- Broader market volatility and interest rate sensitivity for growth stocks.
Closing Decisions
No positions are recommended for closure this week. All holdings are within their minimum holding periods and continue to meet the portfolio’s investment thesis.
Disclaimer: This is not investment advice. Past performance is not indicative of future results. All investments carry risk. Consult a financial advisor before making investment decisions.